Article Information
History
- March 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sarah E. Daugherty, PhD, MPH, Senior Researcher1,*,
- Yinglong Guo, MS, Director1,
- Kevin Heath, MD, MPL, FACP, National Medical Director for Clinical Intelligence2,3,
- Micah C. Dasmariñas, BS, Data Scientist1,
- Karol Giuseppe Jubilo, MS, Data Scientist1,
- Jirapat Samranvedhya, MS, Principal Data Scientist1,
- Marc Lipsitch, DPhil, Professor3 and
- Ken Cohen, MD, FACP, Executive Director Translational Research2,4
- 1OptumLabs at UnitedHealth Group, 5995 Opus Parkway, Minneapolis, MN 55343
- 2OptumCare, KS999-1000PO Box 9472, Minneapolis, MN 55440-9472
- 3Harvard T.H Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115
- 4OptumLabs at UnitedHealth Group, 1707 Cole Blvd., Suite 100, Golden, CO 80401
- ↵*Correspondence to: Sarah E. Daugherty, OptumLabs, 5995 Opus Parkway, Minneapolis, MN 55343, SarahDaugherty{at}uhg.com, 301-335-5294
Posted March 12, 2021.
SARS-CoV-2 infection and risk of clinical sequelae during the post-acute phase: a retrospective cohort study
